UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

American journal of transplantation, 2016-07, Vol.16 (7), p.2085-2096

2016

Volltextzugriff (PDF)

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.662-673

2011

Volltextzugriff (PDF)

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study

Arteriosclerosis, thrombosis, and vascular biology, 2008-04, Vol.28 (4), p.771

2008

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Clinical pharmacology and therapeutics, 2015-07, Vol.98 (1), p.19-24

2015

Volltextzugriff (PDF)

Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy

The Journal of molecular diagnostics : JMD, 2021-09, Vol.23 (9), p.1047-1064

2021

Volltextzugriff (PDF)

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.601-615

2019

Volltextzugriff (PDF)

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

Expert opinion on drug metabolism & toxicology, 2016-05, Vol.12 (5), p.555-565

2016

Volltextzugriff (PDF)

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Clinica chimica acta, 2021-09, Vol.520, p.168-171

2021

Volltextzugriff (PDF)

TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase

The Journal of molecular diagnostics : JMD, 2022-10, Vol.24 (10), p.1051-1063

2022

Volltextzugriff (PDF)

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents

European neuropsychopharmacology, 2024-08, Vol.85, p.5-7

2024

Volltextzugriff (PDF)

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Clinical pharmacology and therapeutics, 2014-07, Vol.96 (1), p.81-89

2014

Volltextzugriff (PDF)

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

The pharmacogenomics journal, 2009-08, Vol.9 (4), p.242-247

2009

Volltextzugriff (PDF)

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

ESMO open, 2023-04, Vol.8 (2), p.101197-101197, Article 101197

2023

Volltextzugriff (PDF)

Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice

Frontiers in pharmacology, 2021-04, Vol.12, p.640032-640032

2021

Volltextzugriff (PDF)

UGT1A9 −275T>A/−2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus‐Treated Kidney Transplant Patients

Clinical pharmacology and therapeutics, 2009-09, Vol.86 (3), p.319-327

2009

Volltextzugriff (PDF)

Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β‐Blocker Users

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.45-50

2009

Volltextzugriff (PDF)

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

The pharmacogenomics journal, 2016-02, Vol.16 (1), p.54-59

2016

Volltextzugriff (PDF)

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.363-373

2013

Volltextzugriff (PDF)

Cytochrome P450 2C9 2 and 3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.288-292

2008

Volltextzugriff (PDF)

CYP2C92 allele increases risk for hypoglycemia in POR1/1 type 2 diabetic patients treated with sulfonylureas

Experimental and clinical endocrinology & diabetes, 2014-01, Vol.122 (1), p.60

2014

Volltextzugriff (PDF)

Effects of CYP Induction by Rifampicin on Tamoxifen Exposure

Clinical pharmacology and therapeutics, 2012-07, Vol.92 (1), p.62-67

2012

Volltextzugriff (PDF)

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii150

2018

Volltextzugriff (PDF)

Covariates of tramadol disposition in the first months of life

British journal of anaesthesia : BJA, 2008-04, Vol.100 (4), p.525-532

2008

Volltextzugriff (PDF)

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

British journal of cancer, 2010-09, Vol.103 (6), p.765-771

2010

Volltextzugriff (PDF)

Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors

British journal of dermatology (1951), 2015-11, Vol.173 (5), p.1338-1339

2015

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(106)
Buchkapitel
(1)

Sprache

Englisch
(107)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe

Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice

UGT1A9 −275T>A/−2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus‐Treated Kidney Transplant Patients

Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β‐Blocker Users

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial

Cytochrome P450 2C9 2 and 3 Polymorphisms and the Dose and Effect of Sulfonylurea in Type II Diabetes Mellitus

CYP2C92 allele increases risk for hypoglycemia in POR1/1 type 2 diabetic patients treated with sulfonylureas

Effects of CYP Induction by Rifampicin on Tamoxifen Exposure

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A

Covariates of tramadol disposition in the first months of life

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer

Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors

Suchergebnisse filtern